XML 69 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
SHARE-BASED COMPENSATION PLANS AND AWARDS (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Assumptions Used in the Determination of Fair Value of Stock Options Awarded
The weighted average assumptions used in the determination of fair value for stock options awarded in 2017, 2016, and 2015 are provided in the table below:
Assumptions
 
2017
 
2016
 
2015
Expected volatility rate
 
20.45%
 
23.71%
 
24.11%
Expected dividend yield
 
2.64%
 
2.31%
 
1.75%
Average risk-free interest rate
 
1.91%
 
1.23%
 
1.45%
Expected term years
 
5.0
 
5.0
 
4.8

Schedule of Activity of Stock Option Awards
A summary of the activity of the Company's stock option awards for 2017, 2016, and 2015 is presented below:
 
2017
 
2016
 
2015
 
Options
 
Weighted-Average Exercise Price
 
Options
 
Weighted-Average Exercise Price
 
Options
 
Weighted-Average Exercise Price
Outstanding at beginning of year
2,363,700

 
$
61

 
2,434,600

 
$
53

 
2,209,800

 
$
46

Granted
745,800

 
80

 
554,000

 
65

 
512,700

 
74

Exercised
(489,300
)
 
44

 
(618,500
)
 
33

 
(271,200
)
 
30

Cancelled, forfeited, or expired
(6,100
)
 
74

 
(6,400
)
 
77

 
(16,700
)
 
77

Outstanding at end of year
2,614,100

 
$
70

 
2,363,700

 
$
61

 
2,434,600

 
$
53

Options exercisable at year-end
1,335,500

 
 
 
1,378,000

 
 
 
1,643,100

 
 
Available for grant at end of year
9,943,033

 
 
 
3,807,724

 
 
 
5,413,250

 
 

Schedule of Remaining Contractual Term and Weighted Average Exercise Price of Stock Options Outstanding and Exercisable
The following table provides the remaining contractual term and weighted average exercise prices of stock options outstanding and exercisable at December 31, 2017:
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Number Outstanding at
December 31, 2017
 
Weighted-Average Remaining Contractual Life (Years)
 
Weighted-Average Exercise Price
 
Number Exercisable at
December 31, 2017
 
Weighted-Average Exercise Price
$18-$35
 
62,500
 
1.7
 
$
27

 
62,500
 
$
27

$36-$50
 
271,500
 
3.2
 
39

 
271,500
 
39

$51-$73
 
823,300
 
7.1
 
67

 
454,000
 
68

$74-$87
 
1,456,800
 
8.0
 
79

 
547,500
 
80

 
 
2,614,100
 
7.1
 
$
70

 
1,335,500
 
$
65


Schedule of Summary of Status of Nonvested Options
A summary of the changes in the Company's nonvested options during the year ended December 31, 2017 is presented below:
Nonvested Options
 
Number of Options
 
Weighted-Average Grant Date Fair Value
Nonvested at January 1, 2017
 
985,700

 
$12.56
Granted
 
745,800

 
$11.79
Vested
 
(446,800
)
 
$13.36
Forfeited or expired
 
(6,100
)
 
$13.89
Nonvested options at December 31, 2017
 
1,278,600

 
$11.82